Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection

Transplantation

Volumn 63, Issue 1, 1997, Pages 39-47

  Halloran, P ^a   Mathew, T ^b   Tomlanovich, S ^b   Groth, C ^b   Hooftman, L ^b   Barker, C ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; CYCLOSPORINE; DOUBLE-BLIND METHOD; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031024728     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199701150-00008     Document Type: Article

References (18)

1. Gulanikar AC, MacDonald AS, Sungertekin U, Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 1992; 53: 323.
2. Tesi RJ, Henry ML, Elkammas EA, Ferguson FM. Predictors of long-term primary cadaveric renal transplant survival. Clin Transplant 1993; 7: 345.
3. Cecka JM. Early rejection: determining the fate of renal transplants. Transplant Proc 1991; 23 (1 Pt 2): 1263.
4. Lindholm A, Ohlman S, Albrechtson D, Tufveson G, Persson M, Persson NH. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by three cyclosporin regimens. Transplantation 1993; 56: 307.
5. Naimark DMJ, Cole E. Determinants of long-term renal allograft survival. Transplant Rev 1994; 8: 93.
6. Lee WA, Gu L, Miksztal AR, Chu N, Leung K, Nelson PH. Bioavailability improvement of mycophenolic acid through amino ester derivatization. Pharm Res 1990; 7: 161.
7. Eugui EM, Allison AC. Immunosuppressive activity of mycophenolate mofetil. Ann NY Acad Sci 1993; 685: 309.
8. Matthews TR. Discovery and rationale for the development of mycophenolate mofetil. In: Lieberman R, Mukherjee A, eds. Principles of drug development in transplantation and autoimmunity. Austin, TX: RG Landes, 1994: 437.
9. Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 1996; 10: 77.
10. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321.
11. Sollinger HW for the U.S. Renal Transplant Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 1995; 60: 225.
12. Tricontinental Mycophenolate Mofetil Renal Transplant Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029.
13. Solez K, Axelson RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
14. Koch GG, Amora IA, Stokes ME, Uryniak TJ. Categorical data analysis. In: Berry DA, ed. Statistical methodology in the pharmaceutical sciences. New York: Marcel Dekker, 1990; 389.
15. Dignam J, Weissfeld L, Anderson S. Methods for bounding the marginal survival distribution. Stat Med 1995; 14: 1985.
16. Lunn M, McNell D. Applying Cox regression to competing risks. Biometrics 1995; 51: 524.
17. Morris RE. New small molecule immunosuppressants for transplantation: review of essential concepts. J Heart Lung Transplant 1993; 12: S2765.
18. Sinclair NR for the Canadian Multicentre Transplant Study Group. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 1992; 147: 645.